<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05050422</url>
  </required_header>
  <id_info>
    <org_study_id>E-60116787-020-67242</org_study_id>
    <nct_id>NCT05050422</nct_id>
  </id_info>
  <brief_title>The Effects of Trunk Impairment on Fatigue and Balance</brief_title>
  <official_title>The Effects of Trunk Impairment on Fatigue and Balance in Children With CP</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Suleyman Demirel University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Suleyman Demirel University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fatigue is a common symptom associated with cerebral palsy (CP); it has been estimated that&#xD;
      up to 40% of adolescents with CP experience fatigue that impacts their quality of life and&#xD;
      daily activities. Although fatigue was stated as the primary symptom, a limited number of&#xD;
      studies were found on secondary motor and nonmotor symptoms related to trunk control in&#xD;
      children when the literature was examined.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 13, 2021</start_date>
  <completion_date type="Anticipated">October 13, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 13, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Trunk Impairment Scale (TIS)</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>PedsQLTM Multidimensional Fatigue Scale (PedsQL-MFS)</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Pediatric Balance Scale (PBS)</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">64</enrollment>
  <condition>Cerebral Palsy</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Study</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Trunk Impairment Scale (TIS), PedsQLTM Multidimensional Fatigue Scale (PedsQL-MFS), Pediatric Balance Scale (PBS)</intervention_name>
    <description>control/study group</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Study</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        aged between 2-18 years old; (2) had a form of CP; (3) had the cognitive competence to&#xD;
        participate to the all assessments.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        The sufferers who had an additional neurological or musculoskeletal disability, unstable&#xD;
        medical conditions, any recent medical intervention (such as tendon lengthening surgery or&#xD;
        botulinum toxin injectionâ€¦) were excluded&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 13, 2021</study_first_submitted>
  <study_first_submitted_qc>September 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 20, 2021</study_first_posted>
  <last_update_submitted>September 13, 2021</last_update_submitted>
  <last_update_submitted_qc>September 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Suleyman Demirel University</investigator_affiliation>
    <investigator_full_name>Mehmet Duray</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cerebral Palsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

